MIGNONE ROBERTO — SEC Form 4 filings
SEC reporting owner CIK 1258394. 23 Form 4 filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2024-06-10 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 1,132,400 shares, $23,596,631 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 519,000 shares @ $17.03 ($8,838,570) in TEVA PHARMACEUTICAL INDUSTRIES LTD, filed 2024-06-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Director | 10 | — | 5 legs · 1,132,400 sh · $23,596,631 | 9 |
| Guardant Health, Inc. (GH) | Director | 13 | — | — | 29 |
Form 4 filings — MIGNONE ROBERTO
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2026-07-22 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 264 @ $0 · Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 4,203 @ $0 · Option exercise (M): 4,203 (derivative) @ $0 · Grant/award (A): 2,711 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 7,242 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 77,400 @ $30.24 | EDGAR |
| 2025-12-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 50,000 @ $26.03 | EDGAR |
| 2025-11-24 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 200,000 @ $24.11 | EDGAR |
| 2025-10-22 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 3,167 @ $0 · Option exercise (M): 3,167 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Guardant Health, Inc. (GH) | Grant/award (A): 6,833 (derivative) @ $0 · Grant/award (A): 4,203 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 9,632 · Option exercise (M): 9,632 (derivative) @ $0 · Grant/award (A): 14,492 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 286,000 @ $22.01 | EDGAR |
| 2024-11-12 | 4 | Guardant Health, Inc. (GH) | Grant/award (A): 19,535 (derivative) @ $0 · Grant/award (A): 12,671 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 519,000 @ $17.03 | EDGAR |
| 2024-06-17 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 21,108 · Option exercise (M): 21,108 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 9,632 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1258394 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →